The FDA is announcing a meeting on Sept. 23 of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee (the Committee) to discuss GR

The FDA is announcing a meeting on Sept. 23 of the Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee (the Committee) to discuss GRAIL Inc.’s Galleri® test premarket approval application. The Galleri® test is a prescription-only blood test intended for screening for the …